Nanoparticles with Streptokinase as Modified Thrombolytic Agents - Abed, Hayder;Alwasiti, Estabraq;Tawfeeq, Amer
51,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
26 °P sammeln
  • Broschiertes Buch

Streptokinase as a thrombolytic agent, is a common drug in treatment of circulatory disorders such as deep vein thrombosis,stroke and heart attack. However, immunogenicity and low biological life-time of the enzyme had limited its clinical applications. The results of this work showed high activity of Streptokinase loaded nanoparticles (Streptokinase loaded Titania nanoparticles,Streptokinase loaded fabricated magnetic nanoparticles supported with basil extraction and Streptokinase loaded fabricated magnetic nanoparticles supported with tannic acid as thrombolytic agent. In addition results…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Streptokinase as a thrombolytic agent, is a common drug in treatment of circulatory disorders such as deep vein thrombosis,stroke and heart attack. However, immunogenicity and low biological life-time of the enzyme had limited its clinical applications. The results of this work showed high activity of Streptokinase loaded nanoparticles (Streptokinase loaded Titania nanoparticles,Streptokinase loaded fabricated magnetic nanoparticles supported with basil extraction and Streptokinase loaded fabricated magnetic nanoparticles supported with tannic acid as thrombolytic agent. In addition results showed activity of -hemitate nanoparticles and basilextraction as thrombolytic agent for thrombus lysis.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Assist prof. Dr.Hayder H. Abed work in Al-Muthanna University and I have interested to in medical Chemistry, Nano particles and disease as a result of blood clot  formation.